Neuroblastoma trials recruiting in Tennessee

All Neuroblastoma trials nationally

Cities in Tennessee

Recruiting trials in Tennessee

• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
  NCT04897321 · Phase: Phase 1 · Ages: Up to 21 Years · Sex: All (male and female) · Tennessee: Memphis
• Familial Investigations of Childhood Cancer Predisposition
  NCT03050268 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Tennessee: Memphis
• Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
  NCT04851119 · Phase: Phase 1, Phase 2 · Ages: 12 Months to 30 Years · Sex: All (male and female) · Tennessee: Memphis